
==== Front
Dev Neurobiol
Dev Neurobiol
10.1002/(ISSN)1932-846X
DNEU
Developmental Neurobiology
1932-8451
1932-846X
John Wiley and Sons Inc. Hoboken

32757416
10.1002/dneu.22777
DNEU22777
Review Article
Review Articles
Understanding microglial diversity and implications for neuronal function in health and disease
DE SCHEPPER et al.
De Schepper Sebastiaan https://orcid.org/0000-0003-0640-2417
1
Crowley Gerard https://orcid.org/0000-0003-0436-1332
1
Hong Soyon https://orcid.org/0000-0002-5744-4871
1 soyon.hong@ucl.ac.uk

1 UK Dementia Research Institute University College London London UK
* Correspondence
Soyon Hong, UK Dementia Research Institute, University College London, Cruciform Building, Gower Street, London WC1E 6BT, UK.
Email: soyon.hong@ucl.ac.uk

24 8 2020
Jul-Aug 2021
81 5 10.1002/dneu.v81.5 507523
21 6 2020
18 11 2019
31 7 2020
© 2020 The Authors. Developmental Neurobiology published by Wiley Periodicals LLC.
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Abstract

Genetic data implicate microglia as central players in brain health and disease, urging the need to better understand what microglia do in the brain. Microglia are critical partners in neuronal wiring and function during development and disease. Emerging literature suggests that microglia have diverse functional roles, raising the intriguing question of which functions of microglia become impaired in disease to undermine proper neuronal function. It is also becoming increasingly clear that microglia exist in heterogeneous cell states. Microglial cell states appear context‐dependent, that is, age, sex, location, and health of their microenvironment; these are further influenced by external signaling factors including gut microbiota and lipid metabolites. These data altogether suggest that microglia exist in functional clusters that impact, and are impacted by, surrounding neuronal microenvironment. However, we still lack understanding of how we can translate microglia cell states into function. Here, we summarize the state‐of‐the‐art on the diverse functions of microglia in relation to neuronal health. Then, we discuss heterogeneity during developing, healthy adult and diseased brains, and whether this may be predetermined by origin and/or regulated by local milieu. Finally, we propose that it is critical to gain high‐resolution functional discernment into microglia‐neuron interactions while preserving the spatial architecture of the tissue. Such insight will reveal specific targets for biomarker and therapeutic development toward microglia‐neuron crosstalk in disease.

Alzheimer's disease
microglia
neuro‐immune crosstalk
synapse
transcriptional heterogeneity
Alzheimer’s SocietyWellcome TrustUK Medical Research CouncilAlzheimer’s Research UK (ARUK) source-schema-version-number2.0
cover-dateJuly/August 2021
details-of-publishers-convertorConverter:WILEY_ML3GV2_TO_JATSPMC version:6.0.7 mode:remove_FC converted:14.09.2021
De SchepperS, CrowleyG, HongS. Understanding microglial diversity and implications for neuronal function in health and disease. Develop Neurobiol.2021;81 :507–523. 10.1002/dneu.22777
==== Body
pmc1 INTRODUCTION

The brain is the most complex, yet, highly organized, organ in our body. Therefore, it is conceivable that microglia, as tissue‐resident macrophages of the brain, exist in particular cell states that reflect the postcode of their residence and which neurons they interact with. Genetic and functional studies in multiple neurologic diseases implicate microglia to play central roles in the clearance and surveillance of their neuronal surroundings, and also in the proper maintenance and homeostasis of synaptic health and function. Recent single‐cell sequencing and proteomic studies collectively suggest microglia to exist in multiple cell states, raising the intriguing question of whether microglia exist in diverse functional states. However, we still do not know the full extent of microglial heterogeneity, and how to translate the transcriptomic cell states to function. Here, we summarize what we currently know regarding microglial diversity at both functional and transcriptomic levels. First, we review the state‐of‐the‐art on microglial function and diversity, in particular their interdependence on the neuronal microenvironment. Then, we review the current knowledge on microglial transcriptional heterogeneity in relation to functions relevant to microglia‐neuron crosstalk. We then discuss how microglial diversity is defined by various factors including origin, local milieu, and impact of peripheral immune signaling. Finally, we highlight current and future directions that we think are critical to gain insight into microglia‐neuron interactions. We propose that microglial cell states should be examined through a high‐resolution spatiotemporal lens, in a manner similar to how we examine neuronal diversity.

2 UNDERSTANDING HOW MICROGLIA IMPACT NEURONAL HOMEOSTASIS AND FUNCTION

Microglia are indispensable for brain wiring. They sculpt and refine neural circuits and influence synaptic development and function. However, remarkably little is known about functional states microglia assume to ensure neuronal homeostasis. Recent genetic and functional studies implicate microglia to play central roles in multiple neurologic diseases, urging the need to better understand microglia‐neuron interactions at the cellular and circuit levels. Here, we briefly review proposed roles of microglia important for neuronal homeostasis and function (Figure 1). We emphasize the importance of location and temporal window, and discuss how these functions could go awry in neurodegenerative diseases.

FIGURE 1 Microglia impact neuronal homeostasis and function. Figure illustrating microglia‐neuron crosstalk in the CNS. Microglia sense their neural environment by proteins encoded by sensome genes, crucial to maintain CNS homeostasis, and rapidly respond to damage or insult. Once excess neural progenitors or debris are detected, microglia initiate their clearing functions via TREM2, CR3 (DAP12), AXL, MER, and other yet‐to‐be‐defined molecules. Additionally, microglia sculpt and refine neural circuits by pruning synapses during specific developmental windows through the complement signaling pathway, fractalkine/ADAM10 signaling, and TREM2‐mediated pathways. Microglia also actively “listen” to adjacent neuronal activity by P2Y12, GABA‐R, β2AR, AchR, and other neurotransmitter receptors

2.1 Microglia as monitors of neuronal activity

In vivo live imaging of microglia in healthy adult cortex shows highly active processes constantly surveying their niche (Davalos et al., 2005; Nimmerjahn, Kirchhoff, & Helmchen, 2005). Multiple studies have shown that this process motility is dependent on changes in neuronal activity (Cserép et al., 2020; Liu et al., 2019; Stowell et al., 2019; Wake, Moorhouse, Jinno, Kohsaka, & Nabekura, 2009). In line, maintaining constant surveillance of the neuronal microenvironment requires significant energy expenditure and microglia display remarkable metabolic flexibility to perform their sensing function (Bernier et al., 2020). The process directionality does not appear to be random. In steady‐state, microglia directly contact neuronal synapses for about 5 min every hour (Wakeet al., 2009). A recent elegant study using super resolution imaging in mice showed that microglial processes largely interact with neuronal somata versus synapses (Cserép et al., 2020). An intriguing question is whether this microglia‐neuron contact directionality shifts toward synapses during critical windows of developmental pruning and during aberrant synapse loss in disease. Indeed, in acute laser‐induced injury, microglial processes rapidly converge to target the site of injury (Davalos et al., 2005). The target‐oriented form of motility is mediated by purinergic signaling, that is, activity/injury‐induced ATP and ADP and P2Y12 receptor on microglia. In microglia‐neuron somatic junctions, microglial P2Y12 directly interacts at potassium channel Kv2.1 clusters on neurons (Cserép et al., 2020).

Microglia‐neuron crosstalk is also mediated through cytokines, neurotransmitters, and neuropeptides. For example, microglia produce neuropeptides and growth factors. An elegant study in healthy adult mice showed that microglia in motor cortex contribute to learning‐dependent spine formation via microglial brain‐derived neurotrophic factor (BDNF) (Parkhurst et al., 2013). It remains unclear what regulates microglial BDNF in this paradigm. In a model of peripheral nerve injury, ATP‐stimulated microglia release BDNF and induce neuronal hyperexcitability by inverting the polarity of neuronal GABA currents (Coull et al., 2005). Further, microglial insulin‐like growth factor‐1 (IGF‐1) promotes survival of neural progenitors in layer V cortical neurons (Parkhurst et al., 2013; Ueno et al., 2013; Ziv et al., 2006). The microglial P2Y12 receptor, but not fractalkine receptor (CX3CR1), has been shown to be critical in neuronal activity‐dependent synaptic plasticity in visual cortex (Lowery, Tremblay, Hopkins, & Majewska, 2017; Schecter et al., 2017; Sipe et al., 2016). P2Y12 signaling also dictates microglial responses during neuronal NMDA receptor activation (Dissing‐Olesen et al., 2014; Eyo et al., 2014), neuropathic pain (Gu et al., 2016) and ischemia (Cserép et al., 2020).

Certain glia‐derived factors such as TNFα and IL‐1β have been reported to impact synaptic activity. For example, TNFα regulates synaptic scaling, a mechanism that allows neurons to stabilize excitatory and inhibitory synaptic weights in response to prolonged periods of reduced activity (Stellwagen & Malenka, 2006). Also, hippocampal IL‐1β has been shown to be necessary for fear‐conditioned memory (Goshen et al., 2007; Rogers et al., 2011). Further, several studies have suggested that microglia express receptors to sense changes in neurotransmitter and neuropeptide concentrations, including metabotropic glutamate receptors (Biber et al., 1999; Taylor, Diemel, Cuzner, & Pocock, 2002; Taylor, Diemel, & Pocock, 2003), GABAA receptors (Lee, Schwab, & McGeer, 2010), GABAB receptors (Kuhn et al., 2004), adrenergic receptors (Färber, Pannasch, & Kettenmann, 2005; Mori et al., 2002; Tanaka, Kashima, Suzuki, Ono, & Sawada, 2002), and acetylcholine receptors (Shytle et al., 2004; Suzuki et al., 2006), among many others. Further, activation of these receptors modulates microglial cytokine release (comprehensively reviewed in York, Bernier, & MacVicar, 2018), including TNFα and IL‐6 in cell culture (Lee et al., 2010; Mori et al., 2002; Shytle et al., 2004) and brain slices (Färber et al., 2005). Interestingly, heterogeneous subpopulations of microglia may exist that express distinct sets of receptors in vivo, especially in regard to age, thus displaying a varying degree of response to a given neurotransmitter or neuropeptide (Pannell et al., 2016; Pannell, Szulzewsky, Matyash, Wolf, & Kettenmann, 2014; Seifert, Pannell, Uckert, Färber, & Kettenmann, 2011). Altogether, changes in neurotransmitters in the microenvironment could stimulate microglia to release inflammatory cytokines and chemokines, thereby adversely impacting nearby neuronal networks. Overall, it is clear that microglia engage multiple neuronal signaling mechanisms, highlighting their role as facilitators of neuronal function in the central nervous system (CNS).

2.2 Microglia as sculptors of neuronal synapses

Microglia enter the CNS around embryonic day 9, making them ideal protagonists in sculpting brain circuitry (Ginhoux et al., 2010). Indeed, alteration in microglial genes leads to sustained defects in brain wiring (for in‐depth review, see Wilton, Dissing‐Olesen, & Stevens, 2019). It is important to note that synaptic pruning during development is highly regulated in a spatiotemporal manner (Boulanger & Shatz, 2004; Hua & Smith,2004). Further, neural circuit refinement is dependent on neuronal activity. It is now becoming increasingly clear that microglia crucially contribute to this activity‐dependent refinement (for in‐depth review, see Neniskyte & Gross, 2017). Several pathways have been implicated in microglia‐mediated synaptic pruning. One critical pruning mechanism that has been studied in the visual system is the classical complement cascade, a highly conserved innate immune pathway that mediates the removal of opsonized debris or pathogens (Gasque, 2004). In the developing visual thalamus, C1q, C3, and CR3 mediate synaptic pruning of retinal ganglion axons (Schafer et al., 2012; Stevens et al., 2007). Interestingly, complement (CR3) does not appear to play a role in developmental synaptic pruning in the hippocampal CA1 stratum radiatum (Weinhard et al., 2018). Whether complement‐mediated synaptic pruning pathway in microglia is involved in developmental neural circuit refinement of other brain regions is yet to be determined. In the postnatal developing hippocampal CA1, the fractalkine signaling pathway (CX3CR1‐CX3CL1) plays a critical role in circuit refinement (Paolicelli et al., 2011; Zhan et al., 2014). It was suggested that microglia contribute to circuit refinement in the developing hippocampus by phagocytosing spines (Paolicelli et al., 2011); however, a follow‐up study using correlative light and electron microscopy (CLEM) in slice cultures showed lack of direct evidence for spine phagocytosis (Weinhard et al., 2018). Further experiments are needed to decipher how microglial CX3CR1 mediates neural circuit refinement in the developing hippocampus. The fractalkine neuroimmune axis, in conjunction with ADAM10, has been shown to be critically involved in microglial engulfment of barrel cortex synaptic inputs after lesioning of mouse whiskers (Gunner et al., 2019). Finally, a recent elegant study showed that TREM2, which is exclusively expressed on myeloid cells and microglia in the CNS (Kiialainen, Hovanes, Paloneva, Kopra, & Peltonen, 2005; Schmid et al., 2002), also plays a role in developmental synapse pruning in the hippocampus, the manipulation of which results in sustained deficits in social behavior (Filipello et al., 2018). Further, mice expressing mutations in DAP12, an adaptor protein for TREM2 signaling, display impaired synaptic maturation (Roumier et al., 2004), suggesting that TREM2‐DAP12 signaling plays an integral role in circuit refinement.

Importantly, microglial engulfment of synapses is activity‐dependent (Gunner et al., 2019; Schafer et al., 2012; Tremblay, Lowery, & Majewska, 2010). Microglia appear to selectively engulf the less active synapses (Schafer et al., 2012), raising the intriguing question of how microglia discern which synapses to engulf. In postnatal organotypic hippocampal slice cultures, and in the absence of additional injury or damage, CLEM showed that microglia engulf synaptic structures through “nibbling,” termed trogocytosis (Weinhard et al., 2018). It will be critical to investigate these microglia‐synapse interactions in vivo using high‐resolution time‐lapse imaging, and how microglia‐neuron interactions shift upon changes in neuronal activity or during disease. Molecularly, there appears to be a balance of “don't‐eat‐me” and “eat‐me” signals on synapses (Lehrman et al., 2018; Rivest, 2018). Indeed, recent data propose CD47/SIRPα as a “don't‐eat‐me” signal regulating microglia‐synapse pruning (Lehrman et al., 2018). Further, exposure of phosphatidylserine on the outer leaflet of membranes is emerging as a vital “eat‐me” signal (Païdassi et al., 2008) on synapses (Györffy et al., 2018; Li et al., 2020) (Scott‐Hewitt EMBO [accepted] 2020). Further experiments are needed to decipher how neuronal activity modulates expression of these signals. Astrocytes also appear to play critical roles; they have been shown to engulf both excitatory and inhibitory synapses in visual thalamus via MEGF10 and MERTK (Chung et al., 2013). Astrocytes also work together with microglia via IL‐33 signaling in spinal cord and thalamus (Vainchtein et al., 2018). Neuronal IL‐33 in the adult hippocampus acts on microglia to remodel the extracellular matrix, allowing enhanced dendritic spine plasticity with effects on fear memory (Nguyen et al., 2020). Finally, it is important to note that some immune pathways that regulate synaptic pruning do not involve microglia. A key example is the major histocompatibility complex I‐paired immunoglobulin‐like receptor B (MHCI‐PirB) pathway (Datwani et al., 2009; Kim et al., 2013; Lee et al., 2014). Both molecules are expressed by neurons, are regulated by neuronal activity, and have been shown to be necessary and sufficient for synaptic elimination in the developing visual system as well as during disease (Kim et al., 2013; Lee et al., 2014; William et al., 2012).

Importantly, embryonic microglial depletion perturbs the inhibitory wiring provided by parvalbumin‐expressing interneurons in the mouse barrel cortex (Thion et al., 2019), suggesting modulation of both excitatory and inhibitory circuitry by microglia. These data altogether suggest that synaptic pruning involves multiple cell types and depending on the circuit, time and brain region, distinct pathways are employed.

2.3 Microglia as local phagocytes and sensors of neuronal environment

As tissue‐resident macrophages of the brain parenchyma, microglia phagocytose apoptotic neurons during development (Parnaik, Raff, & Scholes, 2000) as well as progenitors in the hippocampus (Diaz‐Aparicio et al., 2019; Sierra et al., 2015) and olfactory bulb (Wallace, Lord, Dissing‐Olesen, Stevens, & Murthy, 2020) in adult steady‐state brains. A key mechanism by which microglia phagocytose apoptotic neurons is by Mer and Axl (Fourgeaud et al., 2016). Mice that lack MER and AXL specifically in microglia accumulate neuronal progenitor cells in the subventricular zone, and this phagocytotic process seems to driven by TAM receptor ligands Gas6 and Protein S (Fourgeaud et al., 2016). Importantly, microglial phagocytosis concurs with the upregulation of a unique neurogenic secretome (i.e., VGF, VEGF, FGF2), potentially suggesting a feedback loop for neurogenesis (Diaz‐Aparicio et al., 2020; Elmadany et al., 2020). Alternative to phagocytosis, hippocampal microglia contribute to neuronal cell death via CR3‐DAP12‐dependent production of superoxide ions (Wakselman et al., 2008). Altogether, these examples demonstrate the essential role of microglia in remodeling neural stem cells within different niches of the brain.

Further, microglia act as the primary damage sensors of the CNS. Microglia use a unique sensome that consists of around 100 genes that encode for pattern recognition receptors (Tlr2, Tlr7, Siglec‐H), chemokine receptors (Ccr3, Cx3cr1, Cxcr2, Cxcr4), Fc receptors (Fcgr1, Fcgr3, Fcg2b), purinergic receptors (P2rx7, P2rx4), cytokine receptors (Ccr5), and a broad array of scavenger receptors (Cd36, Marco) (Areschoug & Gordon, 2009; Hickman et al., 2013). Of note, microglial sensome genes are uniformly expressed across brain regions, suggesting that microglia are ubiquitously equipped to perform their sensing function. Microglia also use TREM2‐DAP12 signaling to sense damage‐associated lipids (Wang et al., 2015). Soluble forms of TREM2 produced by proteolytic cleavage regulate phagocytosis and expression of pro‐inflammatory cytokines (Zhong & Chen, 2019). Moreover, soluble TREM2 is increased in cerebrospinal fluid of patients with autosomal dominant AD, implicating its biomarker potential for microglia activation (Suarez‐Calvet et al., 2016). Strikingly, microglia in aged mice shift their sensome toward increased expression of pro‐inflammatory chemokines such as Ccl4, Ccl3, Ccl2, Ccl12, and Cxcl12, suggesting enhanced chemotaxis of monocytes, lymphocytes, and other immune cells (Hickman et al., 2013).

In all these situations, microglia interact with other glial cells including astrocytes (Lee et al., 2010; Liddelow et al., 2017; Skripuletz et al., 2012; Tanuma, Sakuma, Sasaki, & Matsumoto, 2006; Vainchtein et al., 2018; Yu et al., 2019), oligodendrocytes (Cantuti‐Castelvetri et al., 2018; Lloyd et al., 2019; Lloyd & Miron, 2019; Ransohoff, Hafler, & Lucchinetti, 2015; Safaiyan et al., 2016), and pericytes (Attwell, Mishra, Hall, O’Farrell, & Dalkara, 2016; Giannoni et al., 2018; Lendahl, Nilsson, & Betsholtz, 2019; Matsumoto et al., 2018; Nortley et al., 2019). These crosstalks are functionally important but outside the scope of this review; for insights, please refer to: Jha, Jo, Kim, and Suk (2019); Vainchtein and Molofsky (2020); Lloyd and Miron (2019) and Rustenhoven, Jansson, Smyth, and Dragunow (2017). Finally, we need to better understand how microglia communicate with other immune cells of the CNS, including border‐associated macrophages (BAMs) and adaptive immune cells (Kierdorf, Masuda, Jordão, & Prinz, 2019; Korin et al., 2017). Indeed, given recent revelations on the brain's waste pathway including the glymphatic system and the elaborate network of functional lymphatic vessels throughout the brain (Aspelund et al., 2015; Louveau et al., 2015; Lukić, Gluncić, Ivkić, Hubenstorf, & Marusić, 2003; Mesquita, et al., 2018), it will be critical to understand how microglia and BAMs get rid of their waste and work with non‐macrophage immune cells circulating in the lymphatic network to maintain brain homeostasis (Da Mesquita, Fu, & Kipnis, 2018; Mestre, Mori, & Nedergaard, 2020).

2.4 Deciphering which functions of microglia fail in disease

Microglia are increasingly recognized as central players in neurologic diseases. Of note, the use of epilepsy models has uncovered multiple signaling pathways contributing to neuron‐microglia communication during seizure activity, including P2Y12 (Mo et al., 2019), CCL2‐CCR2 (Tian et al., 2017), and CX3CL1 (Eyo et al., 2017). In Alzheimer's disease (AD), there is a strong genetic rationale for immune dysfunction to increase risk for dementia (e.g., CR1, MS4A, PLCG2, ABI3, and TREM2) (Efthymiou & Goate, 2017; Guerreiro, Bras, & Hardy, 2013; Jansen et al., 2019; Kunkle et al., 2019). Key questions now are to decipher how these mutations in microglia impair microglia‐neuron crosstalk to facilitate neuronal loss and dysfunction, and whether we can identify the microglia that have gone awry in neurodegeneration. For instance, EM analysis of microglia in the diseased brain revealed a so‐called “dark microglia,” which has electron‐dense cytoplasm and nucleoplasm under oxidative stress during neurodegeneration (Bisht et al., 2016). Recent data using animal models and patients are helping us understand how microglia that carry mutations in risk genes or loci contribute to major AD pathological hallmarks, including amyloid plaque deposition, maintenance and clearance (Andrews, Fulton‐Howard, & Goate, 2020). Some of these studies have also highlighted major differences between human and mouse microglia (Geirsdottir et al., 2019; Mancuso et al., 2019; Sala Frigerio et al., 2019; Zhou et al., 2020), raising the importance of considering species‐specific differences when investigating neuroimmune interactions. One function of microglia that likely malfunctions in AD is their ability to sense damage. Trem2, a key AD risk gene (Guerreiro, Wojtas, et al., 2013; Jonsson et al., 2013), appears to be critical for this “sensing” ability and downstream damage response. Mice with defective TREM2 signaling display impaired microglial response to injury and amyloid plaque pathology (Kleinberger et al., 2017; Ulland et al., 2017; Wang et al., 2015), a phenotype also demonstrated in human AD brain tissue (Toomey et al., 2020; Ulrich et al., 2014; Wang et al., 2016) (for a recent review on TREM2, please refer to: Deczkowska, Weiner, & Amit, 2020). Further, TREM2 is vital for sensing damaged lipids (Wang et al., 2015), maintaining proper lipid homeostasis (Jaitin et al., 2019; Nugent et al., 2020) and sustaining energy metabolism (Ulland et al., 2017). An intriguing question is whether these microglia also fail to monitor neighboring neuronal health and function. In support of this, loss‐of‐function mutations in TREM2 or DAP12 underlie Nasu–Hakola disease, where patients display progressive presenile dementia (Paloneva et al., 2000, 2002). Moreover, as mentioned above, TREM2 has recently been shown to play a role in microglia‐mediated synaptic refinement in brain development (Filipello et al., 2018). Further studies are warranted to establish the link between TREM2 and synaptic impairment in AD. Another major function of microglia that become dysregulated early in AD is their engulfing of synapses. In AD mouse models, prior to plaque‐related neuroinflammation but when synapses are already vulnerable (Selkoe, 2002; Wyss‐Coray & Rogers, 2012), the synaptic pruning pathway involving the classical complement cascade (C1q, C3, CR3) is reactivated in a region‐specific manner (Dejanovic et al., 2018; Hong et al., 2016; Paolicelli et al., 2017; Shi et al., 2017; Wu et al., 2019). Now, a similar reactivation of the complement pathway in microglia and relevance to synapse loss has been reported in various models of neurologic diseases (Dejanovic et al., 2018; Hong et al., 2016; Lui et al., 2016; Paolicelli et al., 2017; Sellgren et al., 2019; Shi et al., 2017; Vasek et al., 2016; Vukojicic et al., 2019; Werneburg et al., 2020; Wu et al., 2019), implicating the microglial pruning pathway as a potential common therapeutic target across diseases.

As we gain deeper insight into microglial functional states, we will be able to better elucidate how, and which, microglia become dysfunctional at various stages of the disease. This will enable dissection of how microglia contribute to brain dyshomeostasis and gain insight into specific pathways worth targeting to preserve synapses and neuronal function.

3 LINKING MICROGLIAL CELL STATES TO FUNCTION RELEVANT TO NEURON‐MICROGLIA CROSSTALK

Traditionally, microglia have been defined by morphology, ontogeny, density, or “activation” profiles. The recent advent of single‐cell RNA sequencing (scRNA seq) has revealed a high degree of transcriptional heterogeneity that reflects the dynamic CNS microenvironment in space and time. However, to fully define microglial identity, we need to integrate its transcriptional profile with cellular function. Here, we briefly review the state‐of‐the‐art on microglial transcriptional cell states but with an emphasis on the functional clusters they may represent. Further, we highlight here the need to consider the spatiotemporal axis when evaluating microglial cell states and function. We propose that microglia should be defined in their native spatial location or “residential postcodes” (Figure 2).

FIGURE 2 Microglia cell states in adulthood: does postcode matter? Transcriptomic analyses of microglia isolated from different brain regions support the existence of region‐specific functional cell states. Dependent on their local microenvironment or “residential postcode,” microglia acquire functional phenotypes that support local neuronal development and function. GO biological processes are based on enriched transcripts of microglia residing in that particular region (Ayata et al., 2018; De Biase et al., 2017; Grabert et al., 2016)

3.1 Hats microglia wear as brain develops and ages

A key hallmark of tissue‐resident macrophages is their unique plasticity to adapt to functional demands of the tissue in which these cells reside (Gautier et al., 2012; Okabe & Medzhitov, 2014). Accordingly, it is assumed that microglia are most heterogenous during early development, reflecting dynamic periods of neurogenesis and synaptic remodeling (Hammond et al., 2019; Li et al., 2019; Masuda et al., 2019). scRNA seq studies showed at least six major subclasses of microglia during early development, but without appreciable sex differences (Hammond et al., 2019; Masuda et al., 2019). In contrast, sex differences impact adult microglia as demonstrated by the higher antigen‐presenting capacity in male microglia (Guneykaya et al., 2018). Interestingly, one cluster of postnatal microglia, the axon tract‐associated microglia (ATM), appears on unmyelinated axon tracts in corpus callosum and cerebellum around P4/P5 (Hammond et al., 2019). The ATM show enriched expression transcripts involved in lipoprotein metabolism (Apoe, Soat1, Lpl), lysosomal activity (Ctsd, Ctsl, Ctsb), and phagosome formation (Cyba, Clec7a) (Hammond et al., 2019). These enriched transcripts are possibly a reflection of functionally specialized microglia that are actively refining neuronal circuits, taking into account that lipids are the main components of myelin sheets, synapses, and dendrites. A comparable population was characterized by a second scRNA seq study, showing an intimate interaction of ameboid Spp1 + Igf1+Clec7a+ microglia with lipid‐rich oligodendrocytes in the white matter (Li et al., 2019). These data altogether suggest that diverse functional states exist within the white matter, and that these microglial subpopulations may exercise a division of labor. Of note, many of the transcripts expressed by these putative phagocytosing microglia in the white matter are also expressed by disease‐associated microglia (DAM) that surround amyloid plaques in AD mouse models (Keren‐Shaul et al., 2017; Li et al., 2019). Furthermore, outside the CNS, highly similar gene profiles are found in lipid‐associated macrophages within adipose tissues, as well as in aortic macrophages during atherosclerosis that is characterized by the accumulation of extracellular lipids (Bobryshev, Ivanova, Chistiakov, Nikiforov, & Orekhov, 2016; Jaitin et al., 2019). This could point toward a conserved response of myeloid cells across different tissues toward a set of environmental cues that are shared in development and neurodegenerative disease.

During aging, microglia are altered in a region‐specific manner, as demonstrated by the selective upregulation of transcripts involved in cell adhesion and motility in hippocampal microglia, but not in cerebellar microglia, over time (Grabert et al., 2016). This phenotypic shift is consistent with the expansion of certain clusters that were found at very low levels during adulthood (Hammond et al., 2019; Sala Frigerio et al., 2019; Sankowski et al., 2019). A more in‐depth comparison between microglia from adult (P100) and aged (P540) mice highlighted that these two age‐associated clusters were enriched for inflammatory—(Ccl4, Ccl3, Il1b, Cst7) and interferon‐related (Ifitm3, Rtp4, Oasl2) genes respectively, suggesting their possible involvement in age‐related CNS inflammation (Hammond et al., 2019). Moreover, in this study, two other clusters highlight the presence of monocytes and macrophages, indicating the coexistence of ontologically distinct myeloid cells in aged brains (Hammond et al., 2019). It will be interesting to understand the functional implications of such intermixed populations in the aging or injured brain.

3.2 Residence postcode may define microglial cell states

Following development, adult microglia integrate divergent cellular states tied to the brain region of residence (Figure 2). Importantly, scRNA seq of isolated brain regions identified 32 subclusters among telencephalon‐projecting neurons in areas such as cortex, hippocampus, and striatum (Zeisel et al., 2018). As such, neuronal diversity, driven by distinct neuronal subtypes, neurotransmitters and neuropeptides, likely provide niche signals for microglial imprinting in the steady‐state adult brain. For example, cerebellar and hippocampal microglia express transcripts related to energy metabolism, contrasting cortical and striatal microglia that are enriched in immune signaling genes such as Trem2 and SiglecH (Grabert et al., 2016). Further, cerebellar microglia show increased levels of CD68 and genes related to endocytosis and phagocytosis, implicating functional specialization potentially related to ongoing neuronal turnover (Ayata et al., 2018). On the contrary, transcripts in striatal microglia indicate active GTP signaling, whereas microglia in the ventral tegmental area (VTA) showed transcripts involved in Fcγ receptor‐mediated phagocytosis, phagosome maturation and growth factor signaling (Ayata et al., 2018; De Biase et al., 2017). Single‐cell analyses from isolated brain regions have further confirmed metabolic diversity among adult microglia, exemplified by subclusters with marker genes related to lysosomal pathways (Ctsd, Lamp2), cholesterol/lipid metabolic pathways (Plin2, Pld4, Ptgs1), or phagosome activation (Ctss, Rab5c) (Masuda et al., 2019). Considering that many brain disorders are accompanied by changes in brain energy metabolism, it would be interesting to assess metabolic profiles of microglia in vulnerable brain regions in various disease settings (Aldana, 2019). However, some scRNA seq studies in adult microglia from whole brains concluded minimal transcriptional heterogeneity in adult microglia. Sala Frigerio et al. identified only two subclusters (termed H1M and H2M) of microglia in dissected cortex and hippocampus, collectively constituting (80%–90%) of total microglia (Sala Frigerio et al., 2019). Li et al. defined only one homeostatic cluster among Tmem119+ microglia isolated from different brain regions at P60, contrasting earlier reports on regional microglial heterogeneity (Grabert et al., 2016; Li et al., 2019; Masuda et al., 2019). Using deep single‐cell and bulk RNA sequencing on isolated brain regions, the authors found high correlation between microglia from different brain regions and attributed previously described regional differences to non‐microglial populations (Li et al., 2019). Nevertheless, the use of TMEM119 to sort microglia may overlook the existence microglia subpopulations expressing low levels of Tmem119 (Bennett et al., 2016; Masuda et al., 2019). Further, cell isolation protocols induce microglial epigenetic and transcriptomic changes that occur rapidly upon tissue dissociation (Haimon et al., 2018).

Besides microglia, the CNS myeloid compartment consists of BAMs that reside at brain borders, including meninges, perivascular space, and choroid plexus (Goldmann et al., 2016; Kierdorf et al., 2019). BAMs express clear niche‐specific signature genes including Lyve1, P2rx7 (subdural BAM), Pla2g2d, Ccl8 (dural BAM), or Lilra5, Ttr (choroid plexus BAM) (Van Hove et al., 2019). Of interest, BAMs share the expression of particular genetic programs (Lyve1, Cd209f, Cd209, Fcna) with macrophages that reside in vasculature‐associated niches in the lung, fat and dermis, suggesting that macrophages acquire common specialized functions that are imprinted by cues from conserved cross‐tissue niches (Chakarov et al., 2019). In accordance, particular functional attributes including neuronal surveillance and neurotrophic support are not unique to microglia, but are also observed in peripheral macrophages that are associated with neuronal structures. For example, nerve‐associated macrophages are found in the myenteric plexus, part of the enteric nervous system or “little brain of the gut,” where they are involved in providing trophic support for neuronal survival (De Schepper et al., 2018). It will be interesting to investigate whether similar mechanisms of neuroimmune interaction are employed in the brain and in the gut (Verheijden, De Schepper, & Boeckxstaens, 2015).

Altogether, these data suggest that spatiotemporal organization (i.e., brain regions and age) is an important determinant of microglial heterogeneity and functional specialization. Further, microglia communicate with synapses and neuronal soma via their numerous processes, implicating that the subcellular organization of transcripts may hold important information. Taking into account that microglia likely lose processes during sampling and cell isolation protocols that precede the preparation of single‐cell suspensions, in situ sequencing techniques will be critical to decipher which cell states may be fundamental to neuronal homeostasis and function.

4 UNDERSTANDING WHAT DEFINES MICROGLIAL HETEROGENEITY

The existence of microglial heterogeneity raises the question of how these cells are instructed to support developmental and functional requirements of the CNS. As we continually refine our understanding of microglia ontogeny and transcriptional networks, an important goal is to determine how these cells are instructed by their origin versus environment. Microglia and BAMs are separated from the circulation via the blood‐brain barrier, so differentiation trajectories could be attributed to their CNS environment. In addition, peripheral and microbial components have been linked to the imprinting of microglial identity.

4.1 Role of embryonic origin

Microglia and BAMs are unique among tissue‐resident macrophages in that they are derived from primitive progenitors in the yolk‐sac and persist during adulthood, raising the important question of whether their embryonic ontogeny matters for functional diversity in the CNS (Ginhoux et al., 2010; Utz et al., 2020). Fate‐mapping studies have shown that microglia are derived from a primitive wave of erythromyeloid precursors (EMPs) that appear in the blood islands of the yolk‐sac around E7, subsequently giving rise to primitive nucleated erythrocytes and macrophages (Ginhoux et al., 2010; Palis, Robertson, Kennedy, Wall, & Keller, 1999). In contrast, most tissue‐resident macrophages outside of the CNS are derived from a second or “transient‐definitive wave” of EMPs that originate in the yolk‐sac but move to the fetal liver thereafter (Hoeffel et al., 2015). Interestingly, embryonic progenitors segregate as early as E10.5 into CD206+ and CD206– macrophages, suggesting early lineage imprinting (Utz et al., 2020). Further, a subpopulation of HoxB8 + microglia was found to be generated during the “late wave” of EMPs, suggesting that heterogeneity of microglia progenitors may exist prior to CNS infiltration (De et al., 2018). However, it remains unclear whether this heterogeneity of progenitors matters for functional diversity in the developing brain.

Several groups have investigated as to whether hematopoietic stem cell (HSC)—or bone marrow‐derived monocytes engrafted in the CNS could recapitulate the functional phenotype of microglia by using distinct models of microglia depletion and/or HSC‐transplantation models (Bennett et al., 2018; Cronk et al., 2018; Lund et al., 2018; Shemer et al., 2018). Although the engrafted cells exhibit a gene expression profile that is comparable to embryonic microglia, these cells still remained distinct in terms of transcriptome and chromatin states, even after extended time of adaption (6–8 months) to the neural environment. Further, embryonic microglia and engrafted cells differed in their functional response to peripheral lipopolysaccharide (LPS) stimulation, suggesting that HSC‐derived cells are not able to fully acquire the identity of preexisting embryonic microglia (Shemer et al., 2018). This indicates that the microglia‐specific gene signature, characterized by Sall1, Gpr56, P2ry12, and Slc2a5 among others, could be at least partly determined by their embryonic origin. Interestingly, loss of Sall1 in embryonic‐derived microglia induced a pro‐inflammatory phenotype and reduced proliferation of doublecortin‐positive neuroblasts in the hippocampal dentate gyrus, suggestive of decreased neurogenesis (Buttgereit et al., 2016). Further, postnatal ablation of Gpr56 in Cx3cr1 + macrophages resulted in higher density of synapses in stratum lacunosum moleculare of the hippocampus at postnatal week three, suggesting the importance of yolk‐sac signature genes for proper neurodevelopment (Li et al., 2020). An important note here is that microglia of embryonic origins may carry epigenetic programs (so‐called “poised” enhancers) that determine functional diversity (Amit, Winter, & Jung, 2016; Gosselin et al., 2014; Lavin et al., 2014). In this, chromatin accessibility studies at the single‐cell level may provide new insights into microglial heterogeneity and diverse functions.

4.2 Role of the neural environment

In addition to ontogeny, microglia and BAMs are imprinted by environmental signals derived from neighboring neural cells (Bennett et al., 2018; Gosselin et al., 2017; Van Hove et al., 2019). As such, microglia quickly lose their homeostatic signature and deactivate enhancers and transcription factor binding sites within hours after isolation, likely contributing to inconsistent observations of microglia transcriptomes as noted earlier (Gosselin et al., 2017). Microglia are dependent on expression patterns of CSF1 (in cerebellum) and IL‐34 (in forebrain), CX3CL1, transforming growth factor–β (TGF‐β), and others that are unique to the spatiotemporal context of the brain (Butovsky et al., 2013; Kana et al., 2019; Wang et al., 2012). Microglia, like other tissue‐resident macrophages, critically rely on the CSF1R‐CSF1 signaling axis, yet, Csf1 op/op mice (carrying an inactivating mutation in the Csf1 gene) only moderately reduce the presence of adult microglia (Ginhoux et al., 2010). In line, depletion of a super‐enhancer in the Csf1r locus (Csf1r ΔFIRE/ΔFIRE) impairs differentiation of microglia (Rojo et al., 2019). In contrast to Csf1r‐deficient mice, Csf1r ΔFIRE/ΔFIRE mice do not show gross loss of neuronal progenitors, suggesting that CSF1R signaling might be redundant for brain development (Rojo et al., 2019). In fact, microglia rely at least partly on IL‐34, the alternative ligand for CSF1R that is highly expressed by neurons predominantly in the cortex, olfactory nucleus, and the hippocampus (Hickman et al., 2013; Kana et al., 2019). Consequently, genetic deletion of Il34 versus Csf1 has distinct effects on microglia distribution; cortical microglia numbers were unaffected by CSF1 deficiency while cerebellar microglia survival was independent of IL‐34 depletion (Kana et al., 2019). These studies further suggest that regular spacing of microglia in different brain regions could be controlled by gradients of distinct cytokines in their local milieu. A recent study demonstrated a similar interdependency for TGF‐β among CNS tissue‐resident macrophages (Utz et al., 2020). Although TGF‐β is a CNS identity signal that controls microglial maintenance (Butovsky et al., 2013), Tgfbr2 depletion in Vav1+ cells (labeling all hematopoietic progeny from E11.5 onward) does not affect BAMs (Utz et al., 2020), emphasizing the existence of at least two independent developmental pathways among CNS‐resident macrophages. It is interesting to note that BAMs fail to infiltrate and replenish empty niches in Vav1iCreTgfbr2fl/fl mice (Utz et al., 2020). This suggests that other niche‐specific environmental signals regulate migration and maturation, or alternatively, that BAMs and microglia are embryonically “hard‐wired” or prespecified in their brain colonization patterns. Further lineage tracing of microglia and BAMs, in combination with single‐cell transcriptomics, epigenetics as well as functional studies, are needed to delineate these questions.

4.3 Peripheral immune signaling and microglia imprinting

Peripheral signals impact CNS development and function. Systemic inflammation during pregnancy is associated with defects in synaptic connectivity and maturation later in life (Estes & McAllister, 2016; Meyer et al., 2006; Patterson, 2009). Intriguingly, challenging pregnant dams with viral or bacterial components such as polyI:C or LPS shifts early microglia differentiation toward a more advanced developmental stage (Matcovitch‐Natan et al., 2016). In parallel, similar mouse models of maternal immune activation develop behavioral changes and neurodevelopmental defects in adult offspring, suggesting that genetic alterations in microglia during embryonic development is detrimental for proper brain development (Smith, Li, Garbett, Mirnics, & Patterson, 2007). Of interest, germ‐free mice exhibit overt defects in spine formation, paralleled by transcriptomic alterations in excitatory neurons and microglia (Chu et al., 2019). Earlier studies highlighted enrichment of interferon and sensome genes, as well as decreased chromatin accessibility in embryonic microglia isolated from germ‐free animals (Matcovitch‐Natan et al., 2016). Interestingly, microglia in male offspring displayed more transcriptional differences during embryonic development, in contrast to female microglia that exhibited many dysregulated genes linked with adaptive immune responses and chemotaxis during adulthood (Matcovitch‐Natan et al., 2016; Thion et al., 2018). These data suggest that there are sex‐differences in how maternal microbiota impact microglial development and imprinting. Importantly, administration of metabolites of gut microbiota, such as short‐chain fatty acids, was able to reverse some of the transcriptional and morphological changes in germ‐free mice and allowed microglia to acquire their homeostatic transcriptome (Erny et al., 2015). Microbiome composition has changed over evolution, suggesting that microbial diversity might contribute to the observed heterogeneity among different microglia species (Geirsdottir et al., 2019; Youngblut et al., 2019). Although microglia express a conserved core gene program of orthologous genes (Csf1r, P2ry12), a few species‐specific transcriptomes were observed, for example, Fcrls in murine microglia, or C3 and SPP1 within primates (Geirsdottir et al., 2019). Of interest, a recent article further highlighted how peripheral signaling can influence microglial diversity in different brain regions; overexpression of human TNFα resulted in increased expression of transcripts related to complement and inflammation in cortical, striatal, and thalamic microglia, but not in hippocampal nor cerebellar microglia (Süß et al., 2020). Together, further studies are necessary to explore how microglia functional diversity is influenced by signals derived from the periphery, including cytokines, metabolites, and other circulating factors.

In summary, microglial identity is determined by ontological “hard‐wiring” and the progressive imprinting by signals derived from the developing CNS and periphery. Combining these concepts, an intriguing, yet, unsolved question is raised: are cell states predestined or instructed upon arrival at their microenvironmental niche in the CNS? Combining fate‐mapping with in situ analyses and functional assays with single‐cell resolution will provide foundation for future development of targeted therapeutic approaches.

5 CONCLUSION

Over the past decade, the advent of powerful genomic and proteomic tools, along with functional studies in microglia, have significantly enhanced what we know about microglial biology and their impact on neuronal wiring and function during development, steady‐state, and disease. It is also clear that microglia display heterogeneous transcriptomic and diverse functional profiles that are likely determined by the specific brain regions they reside in and the neuronal circuits they are associated with. Critical questions arise: First, do microglia exist in functional clusters? It is still unclear whether transcriptional heterogeneity implicates functional specialization. Future studies are warranted to establish links between cell states and function. It is also unclear whether cell states that microglia assume in disease are beneficial or detrimental for neuronal and brain homeostasis. Gaining a deeper insight into how microglial clusters alter according to functional changes in health and disease will be critical in developing specific targets in microglia to preserve synapses and neuronal function. Importantly, many of these functional attributes may be located at microglial processes; hence, it will be critical to dissect subcellular organization of transcripts as in neurons. Taking into account that microglia likely lose processes as well as physiological profiles during homogenization and cell isolation protocols, in situ sequencing techniques will be key to reveal important and highly regulated subcellular information. Second, various microglial cell states are found throughout life, but it is unclear whether these are different subpopulations or whether they belong to one population of microglia that transitions between cell states in a spatiotemporal context. In line, it remains unanswered as to what extent microglial diversity is dictated by origin versus environment. This is highly relevant for therapeutic purposes to determine whether strategies should be focused on cellular origins and intrinsic features or on better understanding of how the environmental niche imprints microglial transcriptomes and their corresponding epigenetic landscape. Finally, how can we translate findings in mouse microglia to humans? (Böttcher et al., 2018; Geirsdottir et al., 2019; Masuda et al., 2019; Mathys et al., 2019; Sala Frigerio et al., 2019; Zhou et al., 2020) Latest data indicate limited convergence between murine and human microglia, in particular to candidate AD risk genes. One innovative approach to address this conundrum was introduced by two independent groups where they created “chimeric mice,” engrafting human inducible pluripotent stem cell‐ or embryonic stem cell‐derived microglia in brains of immunodeficient mice (Hasselmann et al., 2019; Mancuso et al., 2019). These chimeric models will be a powerful tool to understand how human microglia differ from mouse microglia in vivo and contribution of the brain region‐dependent microenvironment.

Region‐specific vulnerability is a key hallmark across neurologic disorders. Hence, spatiotemporal resolution of microglial cell states and insight into their functional relevance in neuronal health and function will significantly advance efforts to identify targets for biomarker development and treatment in neurologic diseases.

CONFLICT OF INTEREST

All authors declare no competing financial conflict or conflict of interest related to this project.

ACKNOWLEDGMENT

We thank Isabella Noelle Chiong for discussions. This work was supported by the UK Dementia Research Institute which receives its funding from DRILtd, funded by the UK Medical Research Council, Alzheimer's Society and Alzheimer's Research UK (SH, SDS), and Wellcome Trust 4‐year PhD studentship (GC).
==== Refs
REFERENCES

Aldana, B. I. (2019). Microglia‐specific metabolic changes in neurodegeneration. Journal of Molecular Biology, 431 (9 ), 1830–1842. 10.1016/j.jmb.2019.03.006 30878483
Amit, I., Winter, D. R., & Jung, S. (2016). The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis. Nature Immunology, 17 (1 ), 18–25. 10.1038/ni.3325 26681458
Andrews, S. J., Fulton‐Howard, B., & Goate, A. (2020). Interpretation of risk loci from genome‐wide association studies of Alzheimer's disease. The Lancet Neurology, 19 (4 ), 326–335. 10.1016/S1474-4422(19)30435-1 31986256
Areschoug, T., & Gordon, S. (2009). Scavenger receptors: Role in innate immunity and microbial pathogenesis. Cellular Microbiology, 11 (8 ), 1160–1169. 10.1111/j.1462-5822.2009.01326.x 19388903
Aspelund, A., Antila, S., Proulx, S. T., Karlsen, T. V., Karaman, S., Detmar, M., … Alitalo, K. (2015). A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. Journal of Experimental Medicine, 212 (7 ), 991–999. 10.1084/jem.20142290
Attwell, D., Mishra, A., Hall, C. N., O’Farrell, F. M., & Dalkara, T. (2016). What is a pericyte? Journal of Cerebral Blood Flow & Metabolism, 36 (2 ), 451–455. 10.1177/0271678X15610340 26661200
Ayata, P., Badimon, A., Strasburger, H. J., Duff, M. K., Montgomery, S. E., Loh, Y.‐H.‐E., … Schaefer, A. (2018). Epigenetic regulation of brain region‐specific microglia clearance activity. Nature Neuroscience, 21 (8 ), 1049–1060. 10.1038/s41593-018-0192-3 30038282
Bennett, F. C., Bennett, M. L., Yaqoob, F., Mulinyawe, S. B., Grant, G. A., Gephart, M. H., … Barres, B. A. (2018). A combination of ontogeny and CNS environment establishes microglial identity. Neuron, 98 (6 ), 1170–1183.e8. 10.1016/j.neuron.2018.05.014 29861285
Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., … Barres, B. A. (2016). New tools for studying microglia in the mouse and human CNS. Proceedings of the National Academy of Sciences of the United States of America, 113 (12 ), E1738–E1746. 10.1073/pnas.1525528113 26884166
Bernier, L.‐P., York, E. M., Kamyabi, A., Choi, H. B., Weilinger, N. L., & MacVicar, B. A. (2020). Microglial metabolic flexibility supports immune surveillance of the brain parenchyma. Nature Communications, 11 (1 ), 1559‐17. 10.1038/s41467-020-15267-z
Biber, K., Laurie, D. J., Berthele, A., Sommer, B., Tölle, T. R., Gebicke‐Härter, P. J., … Boddeke, H. W. G. M. (1999). Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia. Journal of Neurochemistry, 72 (4 ), 1671–1680. 10.1046/j.1471-4159.1999.721671.x 10098876
Bisht, K., Sharma, K. P., Lecours, C., Gabriela Sánchez, M., El Hajj, H., & Milior, G., … Branchi, I. (2016). Dark microglia: A new phenotype predominantly associated with pathological states. Glia, 64 (5 ), 826–839. 10.1002/glia.22966 26847266
Bobryshev, Y. V., Ivanova, E. A., Chistiakov, D. A., Nikiforov, N. G., & Orekhov, A. N. (2016). Macrophages and their role in atherosclerosis: Pathophysiology and transcriptome analysis. BioMed Research International, 2016 (5 ), 9582430‐13. 10.1155/2016/9582430 27493969
Böttcher, C., Schlickeiser, S., Sneeboer, M. A. M., Kunkel, D., Knop, A., Paza, E., … Priller, J. (2018). Human microglia regional heterogeneity and phenotypes determined by multiplexed single‐cell mass cytometry. Nature Neuroscience, 22 (1 ), 78–90. 10.1038/s41593-018-0290-2 30559476
Boulanger, L. M., & Shatz, C. J. (2004). Immune signalling in neural development, synaptic plasticity and disease. Nature Reviews Neuroscience, 5 (7 ), 521–531. 10.1038/nrn1428 15208694
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., … Weiner, H. L. (2013). Identification of a unique TGF‐β–dependent molecular and functional signature in microglia. Nature Neuroscience, 17 (1 ), 131–143. 10.1038/nn.3599 24316888
Buttgereit, A., Lelios, I., Yu, X., Vrohlings, M., Krakoski, N. R., Gautier, E. L., … Greter, M. (2016). Sall1 is a transcriptional regulator defining microglia identity and function. Nature Immunology, 17 (12 ), 1397–1406. 10.1038/ni.3585 27776109
Cantuti‐Castelvetri, L., Fitzner, D., Bosch‐Queralt, M., Weil, M.‐T., Su, M., Sen, P., … Simons, M. (2018). Defective cholesterol clearance limits remyelination in the aged central nervous system. Science, 359 (6376 ), 684–688. 10.1126/science.aan4183 29301957
Chakarov, S., Lim, H. Y., Tan, L., Lim, S. Y., See, P., Lum, J., … Ginhoux, F. (2019). Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science, 363 (6432 ), eaau0964. 10.1126/science.aau0964 30872492
Chu, C., Murdock, M. H., Jing, D., Won, T. H., Chung, H., Kressel, A. M., … Artis, D. (2019). The microbiota regulate neuronal function and fear extinction learning. Nature, 574 (7779 ), 543–548. 10.1038/s41586-019-1644-y 31645720
Chung, W.‐S., Clarke, L. E., Wang, G. X., Stafford, B. K., Sher, A., Chakraborty, C., … Barres, B. A. (2013). Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature, 504 (7480 ), 394–400. 10.1038/nature12776 24270812
Coull, J. A. M., Beggs, S., Boudreau, D., Boivin, D., Tsuda, M., Inoue, K., … De Koninck, Y. (2005). BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature, 438 (7070 ), 1017–1021. 10.1038/nature04223 16355225
Cronk, J. C., Filiano, A. J., Louveau, A., Marin, I., Marsh, R., Ji, E., … Kipnis, J. (2018). Peripherally derived macrophages can engraft the brain independent of irradiation and maintain an identity distinct from microglia. The Journal of Experimental Medicine, 215 (6 ), 1627–1647. 10.1084/jem.20180247 29643186
Cserép, C., Pósfai, B., Lénárt, N., Fekete, R., László, Z. I., Lele, Z., … Dénes, Á. (2020). Microglia monitor and protect neuronal function through specialized somatic purinergic junctions. Science, 367 (6477 ), 528–537. 10.1126/science.aax6752 31831638
Da Mesquita, S., Fu, Z., & Kipnis, J. (2018). The meningeal lymphatic system: A new player in neurophysiology. Neuron, 100 (2 ), 375–388. 10.1016/j.neuron.2018.09.022 30359603
Datwani, A., McConnell, M. J., Kanold, P. O., Micheva, K. D., Busse, B., Shamloo, M., … Shatz, C. J. (2009). Classical MHCI molecules regulate retinogeniculate refinement and limit ocular dominance plasticity. Neuron, 64 (4 ), 463–470. 10.1016/j.neuron.2009.10.015 19945389
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., … Gan, W.‐B. (2005). ATP mediates rapid microglial response to local brain injury in vivo. Nature Neuroscience, 8 (6 ), 752–758. 10.1038/nn1472 15895084
De Biase, L. M., Schuebel, K. E., Fusfeld, Z. H., Jair, K., Hawes, I. A., Cimbro, R., … Bonci, A. (2017). Local cues establish and maintain region‐specific phenotypes of basal ganglia microglia. Neuron, 95 (2 ), 341–356.e6. 10.1016/j.neuron.2017.06.020 28689984
De, S., Van Deren, D., Peden, E., Hockin, M., Boulet, A., Titen, S., & Capecchi, M. R. (2018). Two distinct ontogenies confer heterogeneity to mouse brain microglia. Development, 145 (13 ), dev152306. 10.1242/dev.152306 29973370
De Schepper, S., Verheijden, S., Aguilera‐Lizarraga, J., Viola, M. F., Boesmans, W., Stakenborg, N., … Boeckxstaens, G. (2018). Self‐maintaining gut macrophages are essential for intestinal homeostasis. Cell, 175 (2 ), 400–415.e13. 10.1016/j.cell.2018.07.048 30173915
Deczkowska, A., Weiner, A., & Amit, I. (2020). The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell, 181 (6 ), 1207–1217. 10.1016/j.cell.2020.05.003 32531244
Dejanovic, B., Huntley, M. A., De Mazière, A., Meilandt, W. J., Wu, T., Srinivasan, K., … Sheng, M. (2018). Changes in the synaptic proteome in tauopathy and rescue of tau‐induced synapse loss by C1q antibodies. Neuron, 100 (6 ), 1322–1336.e7. 10.1016/j.neuron.2018.10.014 30392797
Diaz‐Aparicio, I., Paris, I., Sierra‐Torre, V., Plaza‐Zabala, A., Rodríguez‐Iglesias, N., Márquez‐Ropero, M., … Matute, C. (2019). Microglia actively remodel adult hippocampal neurogenesis through the phagocytosis secretome. Journal of Neuroscience, 7 , 16528–16538. 10.1101/583849
Diaz‐Aparicio, I., Paris, I., Sierra‐Torre, V., Plaza‐Zabala, A., Rodríguez‐Iglesias, N., Márquez‐Ropero, M., … Sierra, A. (2020). Microglia actively remodel adult hippocampal neurogenesis through the phagocytosis secretome. Journal of Neuroscience, 40 (7 ), 1453–1482. 10.1523/JNEUROSCI.0993-19.2019 31896673
Dissing‐Olesen, L., LeDue, J. M., Rungta, R. L., Hefendehl, J. K., Choi, H. B., & MacVicar, B. A. (2014). Activation of neuronal NMDA receptors triggers transient ATP‐mediated microglial process outgrowth. Journal of Neuroscience, 34 (32 ), 10511–10527. 10.1523/JNEUROSCI.0405-14.2014 25100586
Efthymiou, A. G., & Goate, A. M. (2017). Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk. Molecular Neurodegeneration, 12 (1 ), 43. 10.1186/s13024-017-0184-x 28549481
Elmadany, N., de Almeida Sassi, F., Wendt, S., Logiacco, F., Visser, J., Haage, V., … Semtner, M. (2020). The VGF‐derived peptide TLQP21 impairs purinergic control of chemotaxis and phagocytosis in mouse microglia. Journal of Neuroscience, 40 (17 ), 3320–3331. 10.1523/JNEUROSCI.1458-19.2020 32060170
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., … Prinz, M. (2015). Host microbiota constantly control maturation and function of microglia in the CNS. Nature Neuroscience, 18 (7 ), 965–977. 10.1038/nn.4030 26030851
Estes, M. L., & McAllister, A. K. (2016). Maternal immune activation: Implications for neuropsychiatric disorders. Science, 353 (6301 ), 772–777. 10.1126/science.aag3194 27540164
Eyo, U. B., Peng, J., Murugan, M., Mo, M., Lalani, A., Xie, P., … Wu, L.‐J. (2017). Regulation of physical microglia‐neuron interactions by fractalkine signaling after status epilepticus. Eneuro, 3 (6 ), ENEURO.0209–16.2016–14. 10.1523/ENEURO.0209-16.2016
Eyo, U. B., Peng, J., Swiatkowski, P., Mukherjee, A., Bispo, A., & Wu, L. J. (2014). Neuronal hyperactivity recruits microglial processes via neuronal NMDA receptors and microglial P2Y12 receptors after status epilepticus. The Journal of Neuroscience, 34 (32 ), 10528–10540. 10.1523/JNEUROSCI.0416-14.2014 25100587
Färber, K., Pannasch, U., & Kettenmann, H. (2005). Dopamine and noradrenaline control distinct functions in rodent microglial cells. Molecular and Cellular Neurosciences, 29 (1 ), 128–138. 10.1016/j.mcn.2005.01.003 15866053
Filipello, F., Morini, R., Corradini, I., Zerbi, V., Canzi, A., Michalski, B., … Matteoli, M. (2018). The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity. Immunity, 48 (5 ), 979–991.e8. 10.1016/j.immuni.2018.04.016 29752066
Fourgeaud, L., Través, P. G., Tufail, Y., Leal‐Bailey, H., Lew, E. D., Burrola, P. G., … Lemke, G. (2016). TAM receptors regulate multiple features of microglial physiology. Nature, 532 (7598 ), 240–244. 10.1038/nature17630 27049947
Gasque, P. (2004). Complement: A unique innate immune sensor for danger signals. Molecular Immunology, 41 (11 ), 1089–1098. 10.1016/j.molimm.2004.06.011 15476920
Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., … Randolph, G. J. (2012). Gene‐expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nature Immunology, 13 (11 ), 1118–1128. 10.1038/ni.2419 23023392
Geirsdottir, L., David, E., Keren‐Shaul, H., Weiner, A., Bohlen, S. C., Neuber, J., … Prinz, M. (2019). Cross‐species single‐cell analysis reveals divergence of the primate microglia program. Cell, 179 (7 ), 1609–1622.e16. 10.1016/j.cell.2019.11.010 31835035
Giannoni, P., Badaut, J., Dargazanli, C., De Maudave, A. F., Klement, W., Costalat, V., & Marchi, N. (2018). The pericyte–glia interface at the blood–brain barrier. Clinical Science, 132 (3 ), 361–374. 10.1042/CS20171634 29439117
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., … Merad, M. (2010). Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science, 330 (6005 ), 841–845. 10.1126/science.1194637 20966214
Goldmann, T., Wieghofer, P., Jordao, M., Prutek, F., Hagemeyer, N., Frenzel, K., … Prinz, M. (2016). Origin, fate and dynamics of macrophages at central nervous system interfaces. Nature Immunology, 17 (7 ), 797–805. 10.1038/ni.3423 27135602
Goshen, I., Kreisel, T., Ounallah‐Saad, H., Renbaum, P., Zalzstein, Y., Ben‐Hur, T., … Yirmiya, R. (2007). A dual role for interleukin‐1 in hippocampal‐dependent memory processes. Psychoneuroendocrinology, 32 (8–10 ), 1106–1115. 10.1016/j.psyneuen.2007.09.004 17976923
Gosselin, D., Link, V. M., Romanoski, C. E., Fonseca, G. J., Eichenfield, D. Z., Spann, N. J., … Glass, C. K. (2014). Environment drives selectionand function of enhancers controlling tissue‐specific macrophage identities. Cell, 159 (6 ), 1327–1340. 10.1016/j.cell.2014.11.023 25480297
Gosselin, D., Skola, D., Coufal, N. G., Holtman, I. R., Schlachetzki, J. C. M., Sajti, E., … Glass, C. K. (2017). An environment‐dependent transcriptional network specifies human microglia identity. Science, 356 (6344 ), eaal3222. 10.1126/science.aal3222 28546318
Grabert, K., Michoel, T., Karavolos, M. H., Clohisey, S., Baillie, J. K., Stevens, M. P., … McColl, B. W. (2016). Microglial brain region−dependent diversity and selective regional sensitivities to aging. Nature Neuroscience, 19 (3 ), 504–516. 10.1038/nn.4222 26780511
Gu, N., Eyo, U. B., Murugan, M., Peng, J., Matta, S., Dong, H., & Wu, L.‐J. (2016). Microglial P2Y12 receptors regulate microglial activation and surveillance during neuropathic pain. Brain, Behavior, and Immunity, 55 , 82–92. 10.1016/j.bbi.2015.11.007
Guerreiro, R., Bras, J., & Hardy, J. (2013). SnapShot: Genetics of Alzheimer's disease. Cell, 155 (4 ), 968–968.e1. 10.1016/j.cell.2013.10.037 24209629
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., … Hazrati, L. (2013). TREM2 variants in Alzheimer's disease. New England Journal of Medicine, 368 (2 ), 117–127. 10.1056/NEJMoa1211851
Guneykaya, D., Ivanov, A., Hernandez, D. P., Haage, V., Wojtas, B., Meyer, N., … Wolf, S. A. (2018). Transcriptional and translational differences of microglia from male and female brains. Cell Reports, 24 (10 ), 2773–2783.e6. 10.1016/j.celrep.2018.08.001 30184509
Gunner, G., Cheadle, L., Johnson, K. M., Ayata, P., Badimon, A., Mondo, E., … Schafer, D. P. (2019). Sensory lesioning induces microglial synapse elimination via ADAM10 and fractalkine signaling. Nature Neuroscience, 22 (7 ), 1075–1088. 10.1038/s41593-019-0419-y 31209379
Györffy, B. A., Kun, J., Török, G., Bulyáki, É., Borhegyi, Z., Gulyássy, P., … Kardos, J. (2018). Local apoptotic‐like mechanisms underlie complement‐mediated synaptic pruning. Proceedings of the National Academy of Sciences of the United States of America, 115 (24 ), 6303–6308. 10.1073/pnas.1722613115 29844190
Haimon, Z., Volaski, A., Orthgiess, J., Boura‐Halfon, S., Varol, D., Shemer, A., … Jung, S. (2018). Re‐evaluating microglia expression profiles using RiboTag and cell isolation strategies. Nature Immunology, 19 (6 ), 636–644. 10.1038/s41590-018-0110-6 29777220
Hammond, T. R., Dufort, C., Dissing‐Olesen, L., Giera, S., Young, A., Wysoker, A., … Stevens, B. (2019). Single‐cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell‐state changes. Immunity, 50 (1 ), 253–271.e6. 10.1016/j.immuni.2018.11.004 30471926
Hasselmann, J., Coburn, M. A., England, W., Figueroa Velez, D. X., Kiani Shabestari, S., Tu, C. H., … Blurton‐Jones, M. (2019). Development of a chimeric model to study and manipulate human microglia in vivo. Neuron, 103 (6 ), 1016–1033.e10. 10.1016/j.neuron.2019.07.002 31375314
Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L.‐C., Means, T. K., … El Khoury, J.(2013). The microglial sensome revealed by direct RNA sequencing. Nature Neuroscience, 16 (12 ), 1896–1905. 10.1038/nn.3554 24162652
Hoeffel, G., Chen, J., Lavin, Y., Low, D., Almeida, F. F., See, P., … Ginhoux, F. (2015). C‐Myb+ erythro‐myeloid progenitor‐derived fetal monocytes give rise to adult tissue‐resident macrophages. Immunity, 42 (4 ), 665–678. 10.1016/j.immuni.2015.03.011 25902481
Hong, S., Beja‐Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., … Stevens, B. (2016). Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science, 352 (6286 ), 712–716. 10.1126/science.aad8373 27033548
Hua, J. Y., & Smith, S. J. (2004). Neural activity and the dynamics of central nervous system development. Nature Neuroscience, 7 (4 ), 327–332. 10.1038/nn1218 15048120
Jaitin, D. A., Adlung, L., Thaiss, C. A., Weiner, A., Li, B., Descamps, H., … Amit, I. (2019). Lipid‐associated macrophages control metabolic homeostasis in a trem2‐dependent manner. Cell, 178 (3 ), 686–698.e14. 10.1016/j.cell.2019.05.054 31257031
Jansen, I. E., Savage, J. E., Watanabe, K., Bryois, J., Williams, D. M., Steinberg, S., … Posthuma, D. (2019). Genome‐wide meta‐analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nature Genetics, 51 (3 ), 404–413. 10.1038/s41588-018-0311-9 30617256
Jha, M. K., Jo, M., Kim, J.‐H., & Suk, K. (2019). Microglia‐Astrocyte crosstalk: An intimate molecular conversation. The Neuroscientist, 25 (3 ), 227–240. 10.1177/1073858418783959 29931997
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., … Rujescu, D. (2013). Variant of TREM2 associated with the risk of Alzheimer's disease. New England Journal of Medicine, 368 (2 ), 107–116. 10.1056/NEJMoa1211103
Kana, V., Desland, F. A., Casanova‐Acebes, M., Ayata, P., Badimon, A., Nabel, E., … Merad, M. (2019). CSF‐1 controls cerebellar microglia and is required for motor function and social interaction. The Journal of Experimental Medicine, 78 , 2265–2281. 10.1084/jem.20182037
Keren‐Shaul, H., Spinrad, A., Weiner, A., Matcovitch‐Natan, O., Dvir‐Szternfeld, R., Ulland, T. K., … Amit, I. (2017). A unique microglia type associated with restricting development of Alzheimer's disease. Cell, 169 (7 ), 1276–1290.e17. 10.1016/j.cell.2017.05.018 28602351
Kierdorf, K., Masuda, T., Jordão, M. J. C., & Prinz, M. (2019). Macrophages at CNS interfaces: Ontogeny and function in health and disease. Nature Reviews Neuroscience, 20 (9 ), 1–16. 10.1038/s41583-019-0201-x 30518965
Kiialainen, A., Hovanes, K., Paloneva, J., Kopra, O., & Peltonen, L. (2005). Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co‐expressed in the CNS. Neurobiology of Disease, 18 (2 ), 314–322. 10.1016/j.nbd.2004.09.007 15686960
Kim, T., Vidal, G. S., Djurisic, M., William, C. M., Birnbaum, M. E., Garcia, K. C., … Shatz, C. J. (2013). Human LilrB2 is a β‐amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model. Science, 341 (6152 ), 1399–1404. 10.1126/science.1242077 24052308
Kleinberger, G., Brendel, M., Mracsko, E., Wefers, B., Groeneweg, L., Xiang, X., … Parhizkar, S. (2017). The FTD‐like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism. The EMBO Journal, 36 (13 ), 1837–1853. 10.15252/embj.201796516 28559417
Korin, B., Ben‐Shaanan, T. L., Schiller, M., Dubovik, T., Azulay‐Debby, H., Boshnak, N. T., … Rolls, A. (2017). High‐dimensional, single‐cell characterization of the brain's immune compartment. Nature Neuroscience, 20 (9 ), 1300–1309. 10.1038/nn.4610 28758994
Kuhn, S. A., van Landeghem, F. K. H., Zacharias, R., Färber, K., Rappert, A., Pavlovic, S., … Kettenmann, H. (2004). Microglia express GABA(B) receptors to modulate interleukin release. Molecular and Cellular Neurosciences, 25 (2 ), 312–322. 10.1016/j.mcn.2003.10.023 15019947
Kunkle, B. W., Grenier‐Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., … Pericak‐Vance, M. A. (2019). Genetic meta‐analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics, 51 (3 ), 414–430. 10.1038/s41588-019-0358-2 30820047
Lavin, Y., Winter, D., Blecher‐Gonen, R., David, E., Keren‐Shaul, H., Merad, M., … Amit, I. (2014). Tissue‐resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell, 159 (6 ), 1312–1326. 10.1016/j.cell.2014.11.018 25480296
Lee, H., Brott, B. K., Kirkby, L. A., Adelson, J. D., Cheng, S., Feller, M. B., … Shatz, C. J. (2014). Synapse elimination and learning rules co‐regulated by MHC class I H2‐D b. Nature, 509 (7499 ), 195–200. 10.1038/nature13154 24695230
Lee, M., Schwab, C., & McGeer, P. L. (2010). Astrocytes are GABAergic cells that modulate microglial activity. Glia, 59 (1 ), 152–165. 10.1002/glia.21087
Lehrman, E. K., Wilton, D. K., Litvina, E. Y., Welsh, C. A., Chang, S. T., Frouin, A., … Stevens, B. (2018). CD47 protects synapses from excess microglia‐ mediated pruning during development. Neuron, 100 (1 ), 120–134.e6. 10.1016/j.neuron.2018.09.017 30308165
Lendahl, U., Nilsson, P., & Betsholtz, C. (2019). Emerging links between cerebrovascular and neurodegenerative diseases—A special role for pericytes. EMBO Reports, 20 (11 ), e48070. 10.15252/embr.201948070 31617312
Li, Q., Cheng, Z., Zhou, L., Darmanis, S., Neff, N. F., Okamoto, J., … Barres, B. A. (2019). Developmental heterogeneity of microglia and brain myeloid cells revealed by deep single‐cell RNA sequencing. Neuron, 101 (2 ), 207–223.e10. 10.1016/j.neuron.2018.12.006 30606613
Li, T., Chiou, B., Gilman, C. K., Luo, R., Koshi, T., Yu, D., … Piao, X. (2020). A splicing isoform of GPR56 mediates microglial synaptic refinement via phosphatidylserine binding. The EMBO Journal, 4 , e104136. 10.15252/embj.2019104136
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., … Barres, B. A. (2017). Neurotoxic reactive astrocytes are induced by activated microglia. Nature, 541 (7638 ), 481–487. 10.1038/nature21029 28099414
Liu, Y. U., Ying, Y., Li, Y., Eyo, U. B., Chen, T., Zheng, J., … Wu, L.‐J. (2019). Neuronal network activity controls microglial process surveillance in awake mice via norepinephrine signaling. Nature Neuroscience, 22 (11 ), 1771–1781. 10.1038/s41593-019-0511-3 31636449
Lloyd, A. F., Davies, C. L., Holloway, R. K., Labrak, Y., Ireland, G., Carradori, D., … Miron, V. E. (2019). Central nervous system regeneration is driven by microglia necroptosis and repopulation. Nature Neuroscience, 22 (7 ), 1–14. 10.1038/s41593-019-0418-z 30559474
Lloyd, A. F., & Miron, V. E. (2019). The pro‐remyelination properties of microglia in the central nervous system. Nature Reviews Neurology, 15 (8 ), 1–12. 10.1038/s41582-019-0184-2 30542073
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., … Kipnis, J. (2015). Structural and functional features of central nervous system lymphatic vessels. Nature, 523 (7560 ), 337–341. 10.1038/nature14432.26030524
Lowery, R. L., Tremblay, M.‐È., Hopkins, B. E., & Majewska, A. K. (2017). The microglial fractalkine receptor is not required for activity‐dependent plasticity in the mouse visual system. Glia, 65 (11 ), 1744–1761. 10.1002/glia.23192 28836393
Lui, H., Zhang, J., Makinson, S. R., Cahill, M. K., Kelley, K. W., Huang, H.‐Y., … Huang, E. J. (2016). Progranulin deficiency promotes circuit‐specific synaptic pruning by microglia via complement activation. Cell, 165 (4 ), 921–935. 10.1016/j.cell.2016.04.001 27114033
Lukić, I. K., Gluncić, V., Ivkić, G., Hubenstorf, M., & Marusić, A. (2003). Virtual dissection: A lesson from the 18th century. Lancet, 362 (9401 ), 2110–2113. 10.1016/S0140-6736(03)15114-8 14697818
Lund, H., Pieber, M., Parsa, R., Han, J., Grommisch, D., Ewing, E., … Harris, R. A. (2018). Competitive repopulation of an empty microglial niche yields functionally distinct subsets of microglia‐like cells. Nature Communications, 9 (1 ), 1–13. 10.1038/s41467-018-07295-7
Mancuso, R., Van Den Daele, J., Fattorelli, N., Wolfs, L., Balusu, S., Burton, O., … De Strooper, B. (2019). Stem‐cell‐derived human microglia transplanted in mouse brain to study human disease. Nature Neuroscience, 94 , 759. 10.1038/s41593-019-0525-x
Masuda, T., Sankowski, R., Staszewski, O., Böttcher, C., Amann, L., Scheiwe, C., … Reinacher, P. C. (2019). Spatial and temporal heterogeneity of mouse and human microglia at single‐cell resolution. Nature, 566 (7744 ), 1–23. 10.1038/s41586-019-0924-x
Matcovitch‐Natan, O., Winter, D. R., Giladi, A., Vargas Aguilar, S., Spinrad, A., Sarrazin, S., … Amit, I. (2016). Microglia development follows a stepwise program to regulate brain homeostasis. Science, 353 (6301 ), aad8670. 10.1126/science.aad8670 27338705
Mathys, H., Davila‐Velderrain, J., Peng, Z., Gao, F., Mohammadi, S., Young, J. Z., … Tsai, L.‐H. (2019). Single‐cell transcriptomic analysis of Alzheimer's disease. Nature, 570 (7761 ), 1–24. 10.1038/s41586-019-1195-2
Matsumoto, J., Dohgu, S., Takata, F., Machida, T., Hatip, F. F. B., Hatip‐Al‐Khatib, I., … Kataoka, Y. (2018). TNF‐α‐sensitive brain pericytes activate microglia by releasing IL‐6 through cooperation between IκB‐NFκB and JAK‐STAT3 pathways. Brain Research, 1692 , 34–44. 10.1016/j.brainres.2018.04.023 29702085
Mesquita, S., Louveau, A., Vaccari, A., Smirnov, I., Cornelison, R. C., Kingsmore, K. M., … Kipnis, J. (2018). Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease. Nature, 560 (7717 ), 185–191. 10.1038/s41586-018-0368-8 30046111
Mestre, H., Mori, Y., & Nedergaard, M. (2020). The Brain's Glymphatic system: Current controversies. Trends in Neurosciences, 43 (7 ), 458–466. 10.1016/j.tins.2020.04.003 32423764
Meyer, U., Nyffeler, M., Engler, A., Urwyler, A., Schedlowski, M., Knuesel, I., … Feldon, J. (2006). The time of prenatal immune challenge determines the specificity of inflammation‐mediated brain and behavioral pathology. Journal of Neuroscience, 26 (18 ), 4752–4762. 10.1523/JNEUROSCI.0099-06.2006 16672647
Mo, M., Eyo, U. B., Xie, M., Peng, J., Bosco, D. B., Umpierre, A. D., … Wu, L. J. (2019). Microglial P2Y12 receptor regulates seizure‐induced neurogenesis and immature neuronal projections. Journal of Neuroscience, 39 (47 ), 9453–9464. 10.1523/JNEUROSCI.0487-19.2019 31597724
Mori, K., Ozaki, E., Zhang, B., Yang, L., Yokoyama, A., Takeda, I., … Tanaka, J. (2002). Effects of norepinephrine on rat cultured microglial cells that express alpha1, alpha2, beta1 and beta2 adrenergic receptors. Neuropharmacology, 43 (6 ), 1026–1034. 10.1016/s0028-3908(02)00211-3 12423672
Neniskyte, U., & Gross, C. T. (2017). Errant gardeners: Glial‐cell‐dependent synaptic pruning and neurodevelopmental disorders. Nature Reviews Neuroscience, 18 (11 ), 658–670. 10.1038/nrn.2017.110 28931944
Nguyen, P. T., Dorman, L. C., Pan, S., Vainchtein, I. D., Han, R. T., Nakao‐Inoue, H., … Molofsky, A. V. (2020). Microglial remodeling of the extracellular matrix promotes synapse plasticity. Cell, 182 (2 ), 388–403.e15. 10.1016/j.cell.2020.05.050 32615087
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005). Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science, 308 (5726 ), 1314–1318. 10.1126/science.1110647 15831717
Nortley, R., Korte, N., Izquierdo, P., Hirunpattarasilp, C., Mishra, A., Jaunmuktane, Z., … Attwell, D. (2019). Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes. Science, 365 (6450 ), eaav9518–13. 10.1126/science.aav9518 31221773
Nugent, A. A., Lin, K., van Lengerich, B., Lianoglou, S., Przybyla, L., Davis, S. S., … Di Paolo, G. (2020). TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge. Neuron, 105 (5 ), 837–854.e9. 10.1016/j.neuron.2019.12.007 31902528
Okabe, Y., & Medzhitov, R. (2014). Tissue‐specific signals control reversible program of localization and functional polarization of macrophages. Cell, 157 (4 ), 832–844. 10.1016/j.cell.2014.04.016 24792964
Païdassi, H., Tacnet‐Delorme, P., Garlatti, V., Darnault, C., Ghebrehiwet, B., Gaboriaud, C., & Frachet, P. (2008). C1q binds phosphatidylserine and likely acts as a multiligand‐bridging molecule in apoptotic cell recognition. The Journal of Immunology, 180 (4 ), 2329–2338. 10.4049/jimmunol.180.4.2329 18250442
Palis, J., Robertson, S., Kennedy, M., Wall, C., & Keller, G. (1999). Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development, 126 (22 ), 5073–5084.10529424
Paloneva, J., Kestilä, M., Wu, J., Salminen, A., Böhling, T., Ruotsalainen, V., … Peltonen, L. (2000). Loss‐of‐function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nature Genetics, 25 (3 ), 357–361. 10.1038/77153 10888890
Paloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., … Peltonen, L. (2002). Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. The American Journal of Human Genetics, 71 (3 ), 656–662. 10.1086/342259 12080485
Pannell, M., Meier, M. A., Szulzewsky, F., Matyash, V., Endres, M., Kronenberg, G., … Kettenmann, H. (2016). The subpopulation of microglia expressing functional muscarinic acetylcholine receptors expands in stroke and Alzheimer's disease. Brain Structure and Function, 221 (2 ), 1157–1172. 10.1007/s00429-014-0962-y 25523105
Pannell, M., Szulzewsky, F., Matyash, V., Wolf, S. A., & Kettenmann, H. (2014). The subpopulation of microglia sensitive to neurotransmitters/neurohormones is modulated by stimulation with LPS, interferon‐γ, and IL‐4. Glia, 62 (5 ), 667–679. 10.1002/glia.22633 24504982
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., … Gross, C. T. (2011). Synaptic pruning by microglia is necessary for normal brain development. Science, 333 (6048 ), 1456–1458. 10.1126/science.1202529 21778362
Paolicelli, R. C., Jawaid, A., Henstridge, C. M., Valeri, A., Merlini, M., Robinson, J. L., … Rajendran, L. (2017). TDP‐43 depletion in microglia promotes amyloid clearance but also induces synapse loss. Neuron, 95 (2 ), 297–308.e6. 10.1016/j.neuron.2017.05.037 28669544
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., … Gan, W.‐B. (2013). Microglia promote learning‐dependent synapse formation through brain‐derived neurotrophic factor. Cell, 155 (7 ), 1596–1609. 10.1016/j.cell.2013.11.030 24360280
Parnaik, R., Raff, M. C., & Scholes, J. (2000). Differences between the clearance of apoptotic cells by professional and non‐professional phagocytes. Current Biology, 10 (14 ), 857–860. 10.1016/s0960-9822(00)00598-4 10899007
Patterson, P. H. (2009). Immune involvement in schizophrenia and autism: Etiology, pathology and animal models. Behavioural Brain Research, 204 (2 ), 313–321. 10.1016/j.bbr.2008.12.016 19136031
Ransohoff, R. M., Hafler, D. A., & Lucchinetti, C. F. (2015). Multiple sclerosis—A quiet revolution. Nature Reviews Neurology, 11 (5 ), 246. 10.1038/nrneurol.2015.49
Rivest, S. (2018). A ‘don't eat me’ immune signal protects neuronal connections. Nature, 563 (7729 ), 42–43. 10.1038/d41586-018-07165-8 30374080
Rogers, J. T., Morganti, J. M., Bachstetter, A. D., Hudson, C. E., Peters, M. M., Grimmig, B. A., … Gemma, C. (2011). CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. The Journal of Neuroscience, 31 (45 ), 16241–16250. 10.1523/JNEUROSCI.3667-11.2011 22072675
Rojo, R., Raper, A., Ozdemir, D. D., Lefevre, L., Grabert, K., Wollscheid‐Lengeling, E., … Pridans, C. (2019). Deletion of a Csf1r enhancer selectively impacts CSF1R expression and development of tissue macrophage populations. Nature Communications, 10 (1 ), 1–17. 10.1038/s41467-019-11053-8
Roumier, A., Béchade, C., Poncer, J.‐C., Smalla, K.‐H., Tomasello, E., Vivier, E., … Bessis, A. (2004). Impaired synaptic function in the microglial KARAP/DAP12‐deficient mouse. Journal of Neuroscience, 24 (50 ), 11421–11428. 10.1523/JNEUROSCI.2251-04.2004 15601948
Rustenhoven, J., Jansson, D., Smyth, L. C., & Dragunow, M. (2017). Brain pericytes as mediators of neuroinflammation. Trends in Pharmacological Sciences, 38 (3 ), 291–304. 10.1016/j.tips.2016.12.001 28017362
Safaiyan, S., Kannaiyan, N., Snaidero, N., Brioschi, S., Biber, K., Yona, S., … Simons, M. (2016). Age‐related myelin degradation burdens the clearance function of microglia during aging. Nature Neuroscience, 19 (8 ), 995–998. 10.1038/nn.4325 27294511
Sala Frigerio, C., Wolfs, L., Fattorelli, N., Thrupp, N., Voytyuk, I., Schmidt, I., … De Strooper, B. (2019). The major risk factors for alzheimer's disease: Age, sex, and genes modulate the microglia response to Aβ plaques. Cell Reports, 27 (4 ), 1293–1306.e6. 10.1016/j.celrep.2019.03.099 31018141
Sankowski, R., Böttcher, C., Masuda, T., Geirsdottir, L., Sindram, E., Seredenina, T., … Schnell, O. (2019). Mapping microglia states in the human brain through the integration of high‐dimensional techniques. Nature Neuroscience, 22 (12 ), 1–30. 10.1038/s41593-019-0532-y 30559474
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., … Stevens, B. (2012). Microglia sculpt postnatal neural circuits in an activity and complement‐dependent manner. Neuron, 74 (4 ), 691–705. 10.1016/j.neuron.2012.03.026 22632727
Schecter, R. W., Maher, E. E., Welsh, C. A., Stevens, B., Erisir, A., & Bear, M. F. (2017). Experience‐dependent synaptic plasticity in V1 occurs without microglial CX3CR1. Journal of Neuroscience, 37 (44 ), 10541–10553. 10.1523/JNEUROSCI.2679-16.2017 28951447
Schmid, C. D., Sautkulis, L. N., Danielson, P. E., Cooper, J., Hasel, K. W., Hilbush, B. S., … Carson, M. J. (2002). Heterogeneous expression of the triggering receptor expressed on myeloid cells‐2 on adult murine microglia. Journal of Neurochemistry, 83 (6 ), 1309–1320. 10.1046/j.1471-4159.2002.01243.x 12472885
Seifert, S., Pannell, M., Uckert, W., Färber, K., & Kettenmann, H. (2011). Transmitter‐ and hormone‐activated Ca(2+) responses in adult microglia/brain macrophages in situ recorded after viral transduction of a recombinant Ca(2+) sensor. Cell Calcium, 49 (6 ), 365–375. 10.1016/j.ceca.2011.03.005 21536328
Selkoe, D. J. (2002). Alzheimer's disease is a synaptic failure. Science, 298 (5594 ), 789–791. 10.1126/science.1074069 12399581
Sellgren, C. M., Gracias, J., Watmuff, B., Biag, J. D., Thanos, J. M., Whittredge, P. B., … Perlis, R. H. (2019). Increased synapse elimination by microglia in schizophrenia patient‐derived models of synaptic pruning. Nature Neuroscience, 22 (3 ), 374–385. 10.1038/s41593-018-0334-7 30718903
Shemer, A., Grozovski, J., Tay, T. L., Tao, J., Volaski, A., Süß, P., … Jung, S. (2018). Engrafted parenchymal brain macrophages differ from microglia in transcriptome, chromatin landscape and response to challenge. Nature Communications, 9 (1 ), 1–16. 10.1038/s41467-018-07548-5
Shi, Q., Chowdhury, S., Ma, R., Le, K. X., Hong, S., Caldarone, B. J., … Lemere, C. A. (2017). Complement C3 deficiency protects against neurodegeneration in aged plaque‐rich APP/PS1 mice. Science Translational Medicine, 9 (392 ), eaaf6295. 10.1126/scitranslmed.aaf6295 28566429
Shytle, R. D., Mori, T., Townsend, K., Vendrame, M., Sun, N., Zeng, J., … Tan, J. (2004). Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. Journal of Neurochemistry, 89 (2 ), 337–343. 10.1046/j.1471-4159.2004.02347.x 15056277
Sierra, A., Martín‐Suárez, S., Valcárcel‐Martín, R., Pascual‐Brazo, J., Aelvoet, S.‐A., Abiega, O., … Encinas, J. M. (2015). Neuronal hyperactivity accelerates depletion of neural stem cells and impairs hippocampal neurogenesis. Stem Cell, 16 (5 ), 488–503. 10.1016/j.stem.2015.04.003
Sipe, G. O., Lowery, R. L., Tremblay, M. E., Kelly, E. A., Lamantia, C. E., & Majewska, A. K. (2016). Microglial P2Y12 is necessary for synaptic plasticity in mouse visual cortex. Nature Communications, 7 , 10905. 10.1038/ncomms10905
Skripuletz, T., Hackstette, D., Bauer, K., Gudi, V., Pul, R., Voss, E., … Stangel, M. (2012). Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone‐induced demyelination. Brain, 136 (1 ), 147–167. 10.1093/brain/aws262 23266461
Smith, S. E. P., Li, J., Garbett, K., Mirnics, K., & Patterson, P. H. (2007). Maternal immune activation alters fetal brain development through interleukin‐6. Journal of Neuroscience, 27 (40 ), 10695–10702. 10.1523/JNEUROSCI.2178-07.2007 17913903
Stellwagen, D., & Malenka, R. C. (2006). Synaptic scaling mediated by glial TNF‐α. Nature, 440 (7087 ), 1054–1059. 10.1038/nature04671 16547515
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., … Barres, B. A. (2007). The classical complement cascade mediates CNS synapse elimination. Cell, 131 (6 ), 1164–1178. 10.1016/j.cell.2007.10.036 18083105
Stowell, R. D., Sipe, G. O., Dawes, R. P., Batchelor, H. N., Lordy, K. A., Whitelaw, B. S., … Majewska, A. K. (2019). Noradrenergic signaling in the wakeful state inhibits microglial surveillance and synaptic plasticity in the mouse visual cortex. Nature Neuroscience, 22 (11 ), 1782–1792. 10.1038/s41593-019-0514-0 31636451
Suarez‐Calvet, M., Araque Caballero, M. A., Kleinberger, G., Bateman, R. J., Fagan, A. M., Morris, J. C., … Haass, C. (2016). Early changes in CSF sTREM2 in dominantly inherited Alzheimers disease occur after amyloid deposition and neuronal injury. Science Translational Medicine, 8 (369 ), 369ra178. 10.1126/scitranslmed.aag1767
Süß, P., Hoffmann, A., Rothe, T., Ouyang, Z., Baum, W., Staszewski, O., … Schlachetzki, J. C. M. (2020). Chronic peripheral inflammation causes a region‐ specific myeloid response in the central nervous system. Cell Reports, 30 (12 ), 4082–4095.e6. 10.1016/j.celrep.2020.02.109 32209470
Suzuki, T., Hide, I., Matsubara, A., Hama, C., Harada, K., Miyano, K., … Inoue, K. (2006). Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role. Journal of Neuroscience Research, 83 (8 ), 1461–1470. 10.1002/jnr.20850 16652343
Tanaka, K. F., Kashima, H., Suzuki, H., Ono, K., & Sawada, M. (2002). Existence of functional beta1‐ and beta2‐adrenergic receptors on microglia. Journal of Neuroscience Research, 70 (2 ), 232–237. 10.1002/jnr.10399 12271472
Tanuma, N., Sakuma, H., Sasaki, A., & Matsumoto, Y. (2006). Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis. Acta Neuropathologica, 112 (2 ), 195–204. 10.1007/s00401-006-0083-7 16733654
Taylor, D. L., Diemel, L. T., Cuzner, M. L., & Pocock, J. M. (2002). Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up‐regulated in Alzheimer's disease. Journal of Neurochemistry, 82 (5 ), 1179–1191. 10.1046/j.1471-4159.2002.01062.x 12358765
Taylor, D. L., Diemel, L. T., & Pocock, J. M. (2003). Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. Journal of Neuroscience, 23 (6 ), 2150–2160. 10.1523/JNEUROSCI.23-06-02150.2003 12657674
Thion, M. S., Low, D., Silvin, A., Chen, J., Grisel, P., Schulte‐Schrepping, J., … Garel, S. (2018). Microbiome influences prenatal and adult microglia in a sex‐specific manner. Cell, 172 (3 ), 500–516.e16. 10.1016/j.cell.2017.11.042 29275859
Thion, M. S., Mosser, C.‐A., Férézou, I., Grisel, P., Baptista, S., Low, D., … Audinat, E. (2019). Biphasic impact of prenatal inflammation and macrophage depletion on the wiring of neocortical inhibitory circuits. Cell Reports, 28 (5 ), 1119–1126.e4. 10.1016/j.celrep.2019.06.086 31365857
Tian, D.‐S., Peng, J., Murugan, M., Feng, L.‐J., Liu, J.‐L., Eyo, U. B., … Wu, L.‐J. (2017). Chemokine CCL2–CCR2 signaling induces neuronal cell death via STAT3 activation and IL‐1β production after status epilepticus. The Journal of Neuroscience, 37 (33 ), 7878–7892. 10.1523/JNEUROSCI.0315-17.2017 28716963
Toomey, C. E., Heywood, W., Benson, B. C., Packham, G., Mills, K., & Lashley, T. (2020). Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer's disease. Brain Pathology, 136 , 1101. 10.1111/bpa.12842
Tremblay, M.‐È., Lowery, R. L., & Majewska, A. K. (2010). Microglial interactions with synapses are modulated by visual experience. PLoS Biology, 8 (11 ), e1000527. 10.1371/journal.pbio.1000527 21072242
Ueno, M., Fujita, Y., Tanaka, T., Nakamura, Y., Kikuta, J., Ishii, M., & Yamashita, T. (2013). Layer V cortical neurons require microglial support for survival during postnatal development. Nature Neuroscience, 16 (5 ), 543–551. 10.1038/nn.3358 23525041
Ulland, T. K., Song, W. M., Huang, S.‐C.‐C., Ulrich, J. D., Sergushichev, A., Beatty, W. L., … Colonna, M. (2017). TREM2 maintains microglial metabolic fitness in Alzheimer's disease. Cell, 170 (4 ), 649–656.e13. 10.1016/j.cell.2017.07.023 28802038
Ulrich, J. D., Finn, M. B., Wang, Y., Shen, A., Mahan, T. E., Jiang, H., … Holtzman, D. M. (2014). Altered microglial response to Aβ plaques in APPPS1‐21 mice heterozygous for TREM2. Molecular Neurodegeneration, 9 (1 ), 20. 10.1186/1750-1326-9-20 24893973
Utz, S. G., See, P., Mildenberger, W., Thion, M. S., Silvin, A., Lutz, M., … Greter, M. (2020). Early fate defines microglia and non‐parenchymal brain macrophage development. Cell, 181 (3 ), 557–573.e18. 10.1016/j.cell.2020.03.021 32259484
Vainchtein, I. D., Chin, G., Cho, F. S., Kelley, K. W., Miller, J. G., Chien, E. C., … Molofsky, A. V. (2018). Astrocyte‐derived interleukin‐33 promotes microglial synapse engulfment and neural circuit development. Science, 359 (6381 ), 1269–1273. 10.1126/science.aal3589 29420261
Vainchtein, I. D., & Molofsky, A. V. (2020). Astrocytes and microglia: In sickness and in health. Trends in Neurosciences, 43 (3 ), 144–154. 10.1016/j.tins.2020.01.003 32044129
Van Hove, H., Martens, L., Scheyltjens, I., De Vlaminck, K., Antunes, A. R. P., De Prijck, S., … Movahedi, K. (2019). A single‐cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nature Neuroscience, 22 (6 ), 1–24. 10.1038/s41593-019-0393-4 30559474
Vasek, M. J., Garber, C., Dorsey, D., Durrant, D. M., Bollman, B., Soung, A., … Klein, R. S. (2016). A complement–microglial axis drives synapse loss during virus‐induced memory impairment. Nature, 534 (7608 ), 538–543. 10.1038/nature18283 27337340
Verheijden, S., De Schepper, S., & Boeckxstaens, G. E. (2015). Neuron‐macrophage crosstalk in the intestine: A “microglia” perspective. Frontiers in Cellular Neuroscience, 9 , 403. 10.3389/fncel.2015.00403 26528133
Vukojicic, A., Delestrée, N., Fletcher, E. V., Pagiazitis, J. G., Sankaranarayanan, S., Yednock, T. A., … Mentis, G. Z. (2019). The classical complement pathway mediates microglia‐dependent remodeling of spinal motor circuits during development and in SMA. Cell Reports, 29 (10 ), 3087–3100.e7. 10.1016/j.celrep.2019.11.013 31801075
Wake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S., & Nabekura, J. (2009). Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. Journal of Neuroscience, 29 (13 ), 3974–3980. 10.1523/JNEUROSCI.4363-08.2009 19339593
Wakselman, S., Bechade, C., Roumier, A., Bernard, D., Triller, A., & Bessis, A. (2008). Developmental neuronal death in hippocampus requires the microglial CD11b Integrin and DAP12 immunoreceptor. The Journal of Neuroscience, 28 (32 ), 8138–8143. 10.1523/JNEUROSCI.1006-08.2008 18685038
Wallace, J., Lord, J., Dissing‐Olesen, L., Stevens, B., & Murthy, V. N. (2020). Microglial depletion disrupts normal functional development of adult‐born neurons in the olfactory bulb. eLife, 9 , 399. 10.7554/eLife.50531
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., … Colonna, M. (2015). TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell, 160 (6 ), 1061–1071. 10.1016/j.cell.2015.01.049 25728668
Wang, Y., Szretter, K. J., Vermi, W., Gilfillan, S., Rossini, C., Cella, M., … Colonna, M. (2012). IL‐34 is a tissue‐restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nature Immunology, 13 (8 ), 753–760. 10.1038/ni.2360 22729249
Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., … Colonna, M. (2016). TREM2‐mediated early microglial response limits diffusion and toxicity of amyloid plaques. Journal of Experimental Medicine, 213 (5 ), 667–675. 10.1084/jem.20151948
Weinhard, L., Bartolomei, G., Bolasco, G., Machado, P., Schieber, N. L., Neniskyte, U., … Gross, C. T. (2018). Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction. Nature Communications, 9 (1 ), 1–14. 10.1038/s41467-018-03566-5
Werneburg, S., Jung, J., Kunjamma, R. B., Ha, S.‐K., Luciano, N. J., Willis, C. M., … Schafer, D. P. (2020). Targeted complement inhibition at synapses prevents microglial synaptic engulfment and synapse loss in demyelinating disease. Immunity, 52 (1 ), 167–182.e7. 10.1016/j.immuni.2019.12.004 31883839
William, C. M., Andermann, M. L., Goldey, G. J., Roumis, D. K., Reid, R. C., Shatz, C. J., … Hyman, B. T. (2012). Synaptic plasticity defect following visual deprivation in Alzheimer's disease model transgenic mice. Journal of Neuroscience, 32 (23 ), 8004–8011. 10.1523/JNEUROSCI.5369-11.2012 22674275
Wilton, D. K., Dissing‐Olesen, L., & Stevens, B. (2019). Neuron‐glia signaling in synapse elimination. Annual Review of Neuroscience, 42 (1 ), 107–127. 10.1146/annurev-neuro-070918-050306
Wu, T., Dejanovic, B., Gandham, V. D., Gogineni, A., Edmonds, R., Schauer, S., … Hanson, J. E. (2019). Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy. Cell Reports, 28 (8 ), 2111–2123.e6. 10.1016/j.celrep.2019.07.060 31433986
Wyss‐Coray, T., & Rogers, J. (2012). Inflammation in Alzheimer disease‐a brief review of the basic science and clinical literature. Cold Spring Harbor Perspectives in Medicine, 2 (1 ), a006346. 10.1101/cshperspect.a006346 22315714
York, E. M., Bernier, L.‐P., & MacVicar, B. A. (2018). Microglial modulation of neuronal activity in the healthy brain. Developmental Neurobiology, 78 (6 ), 593–603. 10.1002/dneu.22571 29271125
Youngblut, N. D., Reischer, G. H., Walters, W., Schuster, N., Walzer, C., Stalder, G., … Farnleitner, A. H. (2019). Host diet and evolutionary history explain different aspects of gut microbiome diversity among vertebrate clades. Nature Communications, 10 (1 ), 2200–2215. 10.1038/s41467-019-10191-3
Yu, T., Zhang, X., Shi, H., Tian, J., Sun, L., Hu, X., … Du, D. (2019). P2Y12 regulates microglia activation and excitatory synaptic transmission in spinal lamina II neurons during neuropathic pain in rodents. Cell Death & Disease, 10 (3 ), 165. 10.1038/s41419-019-1425-4 30778044
Zeisel, A., Hochgerner, H., Lönnerberg, P., Johnsson, A., Memic, F., van der Zwan, J., … Linnarsson, S. (2018). Molecular architecture of the mouse nervous system. Cell, 174 (4 ), 999–1014.e22. 10.1016/j.cell.2018.06.021 30096314
Zhan, Y., Paolicelli, R. C., Sforazzini, F., Weinhard, L., Bolasco, G., Pagani, F., … Gross, C. T. (2014). Deficient neuron‐microglia signaling results in impaired functional brain connectivity and social behavior. Nature Neuroscience, 17 (3 ), 400–406. 10.1038/nn.3641 24487234
Zhong, L., & Chen, X.‐F. (2019). The emerging roles and therapeutic potential of soluble TREM2 in Alzheimer's disease. Frontiers in Aging Neuroscience, 11 , 328. 10.3389/fnagi.2019.00328 32038221
Zhou, Y., Song, W. M., Andhey, P. S., Swain, A., Levy, T., Miller, K. R., … Colonna, M. (2020). Human and mouse single‐nucleus transcriptomics reveal TREM2‐dependent and TREM2‐independent cellular responses in Alzheimer's disease. Nature Medicine, 26 (1 ), 131–142. 10.1038/s41591-019-0695-9
Ziv, Y., Ron, N., Butovsky, O., Landa, G., Sudai, E., Greenberg, N., … Schwartz, M. (2006). Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nature Neuroscience, 9 (2 ), 268–275. 10.1038/nn1629 16415867

